These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11700578)

  • 1. Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.
    Lass-Flörl C; Dierich MP; Fuchs D; Semenitz E; Ledochowski M
    Clin Infect Dis; 2001 Dec; 33(12):E135-6. PubMed ID: 11700578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sertraline in the treatment of premenstrual dysphoric disorder].
    Culav-Sumić J; Skocilić Z; Jukić V
    Lijec Vjesn; 1999; 121(7-8):234-8. PubMed ID: 10573958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.
    Halbreich U; Kahn LS
    Expert Opin Pharmacother; 2003 Nov; 4(11):2065-78. PubMed ID: 14596660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders.
    Alpay FB; Turhan NO
    Int J Fertil Womens Med; 2001; 46(4):228-31. PubMed ID: 11563834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of premenstrual dysphoric disorder and its treatment.
    Steiner M
    Lancet; 2000 Sep; 356(9236):1126-7. PubMed ID: 11030287
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating premenstrual dysphoric disorder using serotonin agents.
    Lin J; Thompson DS
    J Womens Health Gend Based Med; 2001 Oct; 10(8):745-50. PubMed ID: 11703886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemic episodes in a case of Prementrual Dysphoric Disorder on sertraline.
    Santra Dhali R; Banerjee P; Munshi S; Chaudhuri PR
    Indian J Pharmacol; 2015; 47(5):567-8. PubMed ID: 26600652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
    Pearlstein TB; Halbreich U; Batzar ED; Brown CS; Endicott J; Frank E; Freeman EW; Harrison WM; Haskett RF; Stout AL; Yonkers KA
    J Clin Psychiatry; 2000 Feb; 61(2):101-9. PubMed ID: 10732657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of managed care charges among patients treated with selective serotonin reuptake inhibitors for premenstrual dysphoric disorder.
    Endicott J; McLaughlin TP; Grudzinski AN
    J Clin Psychiatry; 2003 Dec; 64(12):1511-6. PubMed ID: 14728114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to sertraline treatment of severe premenstrual syndromes.
    Freeman EW; Sondheimer SJ; Polansky M; Garcia-Espagna B
    J Clin Psychiatry; 2000 Aug; 61(8):579-84. PubMed ID: 10982201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
    Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is sertraline an effective therapy for premenstrual dysphoric disorder?
    Fernandes O; Por CP; Evans MF
    Can Fam Physician; 1998 Apr; 44():765-7. PubMed ID: 9585849
    [No Abstract]   [Full Text] [Related]  

  • 15. Sertraline for premenstrual dysphoric disorder.
    Cohen LS
    JAMA; 1998 Feb; 279(5):357-8. PubMed ID: 9459467
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates.
    Costa Silva RA; da Silva CR; de Andrade Neto JB; da Silva AR; Campos RS; Sampaio LS; do Nascimento FBSA; da Silva Gaspar B; da Cruz Fonseca SG; Josino MAA; Grangeiro TB; Gaspar DM; de Lucena DF; de Moraes MO; Cavalcanti BC; Nobre Júnior HV
    Microb Pathog; 2017 Jun; 107():341-348. PubMed ID: 28411060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
    Halbreich U; Smoller JW
    J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
    Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
    Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis.
    Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y
    BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.